<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02949297</url>
  </required_header>
  <id_info>
    <org_study_id>771-0013</org_study_id>
    <nct_id>NCT02949297</nct_id>
  </id_info>
  <brief_title>Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study</brief_title>
  <acronym>ELEVATE</acronym>
  <official_title>Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endologix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent
      Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent
      Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA). The
      primary objective is to evaluate treatment success at 12 months with the Ovation Alto
      Abdominal Stent Graft system. The study will have up to 16 sites, and up to 75 patients based
      on attrition rates. The follow-up intervals will be at 1, 6, and 12 months following initial
      implant procedure.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 30, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects with treatment success</measure>
    <time_frame>12 months</time_frame>
    <description>Treatment success is defined as technical success, freedom from type I and III endoleaks at 12 months, freedom from stent graft migration &gt; 10m at 12 months compared to 1 month baseline, freedom from AAA enlargement &gt;5mm at 12 months (compared to 1-month baseline, freedom from AAA rupture through 12 months, freedom from conversion to open repair through 12 months, stent graft stenosis, occlusion or kink requiring secondary intervention through 12 months, thromboembolic event attributable to stent graft requiring secondary intervention through 12 months, stent fracture requiring secondary intervention through 12 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and Classification of Endoleaks</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Migration &gt; 10mm</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AAA enlargement &gt; 5mm</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AAA rupture</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion to open repair</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Secondary Interventions</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AAA-related mortality</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device-related Adverse Events (AEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Loss of patency</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent fracture</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboembolic event</measure>
    <time_frame>1, 6, and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>Ovation Alto Abdominal Stent Graft System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Endovascular repair of AAA using the Ovation Alto Abdominal Stent Graft System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ovation Alto Abdominal Stent Graft System</intervention_name>
    <description>Repair of Abdominal Aortic Aneurysm with Ovation Alto Abdominal Stent Graft System</description>
    <arm_group_label>Ovation Alto Abdominal Stent Graft System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria include:

          1. Patient has adequate iliac/femoral access compatible with the required delivery
             systems.

          2. Patient has non-aneurysmal proximal aortic neck.

          3. Patient has non-aneurysmal distal iliac landing zone.

        Exclusion Criteria include:

          1. Patient has dissecting aneurysm.

          2. Patient has acutely ruptured aneurysm.

          3. Patient has need for emergent surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sean Lyden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abrazo Arizona Heart Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carle Foundation Hospital</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University at Buffalo Clinical Translational Research Center/Kaleida Health/GVI/Buffalo General Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Hospital</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Central Heart</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellmont CVA Heart Institute</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Heart and Vascular Research</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.endologix.com</url>
    <description>Endologix Website</description>
  </link>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2016</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abdominal</keyword>
  <keyword>aortic</keyword>
  <keyword>aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

